BridgeMD
New treatment option for Alveolar Bone Loss
Official title Evaluation of Erythropoietin on Alveolar Ridge Preservation
ClinicalTrials.gov ID: NCT06513039
What this study is testing
What is Erythropoietin carried on chitosan carrier?
Erythropoietin carried on chitosan carrier is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for alveolar bone loss.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- regenerative materials would help in decreasing post-extraction resorption in sites indicated for placement of a conventional bridge or prosthetically driven implant. Erythropoietin (EPO) is a growth factor that promotes angiogenesis and bone regeneration by stimulating osteoblastic differentiation and by inhibiting osteoclastic resorption.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- Age range (18-40).
- Hopeless teeth indicated for extraction such as root fractures, caries, internal root resorption, external root resorption, endodontic failures.
- Systemically free patients using Cornell Medical Index-Health Questionnaire [36].
- Patients diagnosed with intact surrounding alveolar bone (socket type I) [37].
- Maxillary anterior teeth and/or premolars indicated for extraction.
You likely can't join if
- Smokers
- Occlusal trauma at the site of the graft
- Pregnancy and lactation
- Bad compliance with the plaque control instructions following initial therapy.
See the full eligibility criteria
- Age range (18-40).
- Hopeless teeth indicated for extraction such as root fractures, caries, internal root resorption, external root resorption, endodontic failures.
- Systemically free patients using Cornell Medical Index-Health Questionnaire [36].
- Patients diagnosed with intact surrounding alveolar bone (socket type I) [37].
- Maxillary anterior teeth and/or premolars indicated for extraction.
- Enough zone of keratinized tissue (≥2 mm).
- Smokers
- Occlusal trauma at the site of the graft
- Pregnancy and lactation
- Bad compliance with the plaque control instructions following initial therapy.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.